Infinity Pharmaceuticals Inc (INFI)
3.40
+0.00 +0.00%
NASDAQ
Feb 24, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.592M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.71 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -41.28M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 39.72% |
| Profit Margin (Quarterly) | -1.92K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 300.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 124.05 |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -3.540 |
| Free Cash Flow (Quarterly) | -7.883M |
| Return on Equity | Upgrade |
View All INFI News
News
-
WireHeadlineTime (ET)
-
Yahoo02/20 07:40
-
SA Breaking News02/18 15:39
-
Yahoo02/18 10:02
-
Yahoo02/18 08:30
-
MT Newswires02/18 08:15
-
MT Newswires02/12 10:51
-
SA Breaking News02/12 09:11
-
Yahoo02/12 08:30
-
Yahoo02/12 08:10
-
MT Newswires02/12 08:03
-
MT Newswires02/11 17:46
-
Yahoo02/11 16:01
-
Yahoo02/11 12:38
-
PR Newswire02/11 09:31
-
Yahoo02/11 09:25
-
Yahoo02/11 09:16
-
SA Breaking News02/11 08:27
-
SA Breaking News02/11 08:02
-
Yahoo02/11 07:15
-
Yahoo02/10 16:05
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/03/2021 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release |
| 03/03/2021 | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/09/2020 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings Result for 2020 |
| 11/09/2020 16:30 EST | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020 |
| 07/30/2020 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings Result for 2020 |
| 07/30/2020 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020 |
| 06/17/2020 | Misc | Infinity Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/11/2020 16:30 EDT | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/11/2020 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 03/03/2020 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Mar. 03, 2021
- Last Earnings Release: Nov. 09, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.40 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement
